A Study of Biospecimen Molecular Analysis in Patients with Gastrointestinal Cancers

Overview

About this study

The purpose of this study is to perform molecular analysis with tumor and related tissues, and peripheral blood, obtained from patients with GI cancers and to analyze the data in association with their clinical and pathological characteristics including but not limited to cancer diagnosis, treatment response and survival outcomes. 

 

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age ≥ 18.
  • Cytologically or histologically confirmed GI cancers.
  • Able to consent.

Exclusion Criteria:

  • Individuals < 18 years.
  • Vulnerable patients.
  • Unable to provide informed consent.
     

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Harry Yoon, M.D.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available